Cerebral gigantism.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000365:Age Determination by Skeleton; D000886:Anthropometry; D001827:Body Height; D001835:Body Weight; D002648:Child; D003878:Dermatoglyphics; D005149:Facial Expression; D005260:Female; D005877:Gigantism / Q000150:complications* / Q000000981:diagnostic imaging; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin; D008607:Intellectual Disability / Q000150:complications; D008297:Male; D008797:Metyrapone; D009461:Neurologic Manifestations; D010912:Pituitary-Adrenal Function Tests; D011581:Psychological Tests; D014831:Voice
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D007328:Insulin; D008797:Metyrapone